Trials / Completed
CompletedNCT02504606
Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
A Randomized, Open-label, Single Dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial was evaluated to compare the safety and pharmacokinetics of Besylsartan with Amosartan, which was available commercially after single oral dose in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Besylsartan | Amlodipin besylate 6.944mg+Losartan K 100mg |
| DRUG | Amosartan | Amlodipin besylate 7.841mg+Losartan K 100mg |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2015-07-22
- Last updated
- 2015-07-22
Source: ClinicalTrials.gov record NCT02504606. Inclusion in this directory is not an endorsement.